Healthcare provider profile · identity verified

Joanna M Brady, MD

Family Practice · MERCERSBURG, PA · NPI 1285673582

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	558	142
Atorvastatin Calcium	Atorvastatin Calcium	448	115
Omeprazole	Omeprazole	363	92
Levothyroxine Sodium	Levothyroxine Sodium	335	74
Amlodipine Besylate	Amlodipine Besylate	315	99
Metoprolol Succinate	Metoprolol Succinate	276	79
Metformin Hcl	Metformin Hcl	272	70
Pantoprazole Sodium	Pantoprazole Sodium	265	65
Losartan Potassium	Losartan Potassium	231	62
Furosemide	Furosemide	220	57
Hydrochlorothiazide	Hydrochlorothiazide	211	53
Jardiance	Empagliflozin	200	37
Potassium Chloride	Potassium Chloride	196	48
Gabapentin	Gabapentin	187	52
Simvastatin	Simvastatin	171	40
Albuterol Sulfate Hfa	Albuterol Sulfate	160	47
Metoprolol Tartrate	Metoprolol Tartrate	148	37
Buspirone Hcl	Buspirone Hcl	144	45
Rosuvastatin Calcium	Rosuvastatin Calcium	144	43
Sertraline Hcl	Sertraline Hcl	143	33
Clopidogrel	Clopidogrel Bisulfate	135	30
Eliquis	Apixaban	123	32
Carvedilol	Carvedilol	109	25
Pravastatin Sodium	Pravastatin Sodium	99	28
Ozempic	Semaglutide	97	24
Amitriptyline Hcl	Amitriptyline Hcl	96	29
Trazodone Hcl	Trazodone Hcl	92	27
Montelukast Sodium	Montelukast Sodium	91	25
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	88	31
Trulicity	Dulaglutide	88	12
Meloxicam	Meloxicam	87	22
Prednisone	Prednisone	86	47
Venlafaxine Hcl Er	Venlafaxine Hcl	86	13
Spironolactone	Spironolactone	85	20
Ezetimibe	Ezetimibe	81	19
Metformin Hcl Er	Metformin Hcl	81	23
Tamsulosin Hcl	Tamsulosin Hcl	81	23
Allopurinol	Allopurinol	80	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	77	24
Celecoxib	Celecoxib	73	27
Lorazepam	Lorazepam	73	14
Alprazolam	Alprazolam	71	19
Duloxetine Hcl	Duloxetine Hcl	71	20
Esomeprazole Magnesium	Esomeprazole Magnesium	70	16
Citalopram Hbr	Citalopram Hydrobromide	69	22
Synthroid	Levothyroxine Sodium	68	16
Ropinirole Hcl	Ropinirole Hcl	66	14
Glimepiride	Glimepiride	58	11
Fluticasone Propionate	Fluticasone Propionate	55	21
Escitalopram Oxalate	Escitalopram Oxalate	54	17
Glipizide	Glipizide	49	12
Atenolol	Atenolol	48	suppressed
Hydralazine Hcl	Hydralazine Hcl	48	11
Novolog Flexpen	Insulin Aspart	48	14
Oxybutynin Chloride Er	Oxybutynin Chloride	48	14
Tramadol Hcl	Tramadol Hcl	47	17
Doxycycline Hyclate	Doxycycline Hyclate	44	34
Quetiapine Fumarate	Quetiapine Fumarate	44	11
Famotidine	Famotidine	43	15
Dutasteride	Dutasteride	42	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	42	suppressed
Pregabalin	Pregabalin	42	11
Azithromycin	Azithromycin	41	37
Fenofibrate	Fenofibrate	41	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	37	suppressed
Levetiracetam	Levetiracetam	37	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	37	suppressed
Warfarin Sodium	Warfarin Sodium	37	suppressed
Alendronate Sodium	Alendronate Sodium	35	14
Bupropion Xl	Bupropion Hcl	35	suppressed
Januvia	Sitagliptin Phosphate	35	suppressed
Enalapril Maleate	Enalapril Maleate	34	suppressed
Xarelto	Rivaroxaban	34	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	33	11
Clonazepam	Clonazepam	33	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	33	suppressed
Amoxicillin	Amoxicillin	32	22
Triamcinolone Acetonide	Triamcinolone Acetonide	32	18
Zolpidem Tartrate	Zolpidem Tartrate	32	suppressed
Baclofen	Baclofen	31	suppressed
Cefuroxime	Cefuroxime Axetil	31	26
Ibuprofen	Ibuprofen	30	suppressed
Ramipril	Ramipril	30	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Irbesartan	Irbesartan	28	suppressed
Nystatin	Nystatin	28	14
Finasteride	Finasteride	26	suppressed
Fluconazole	Fluconazole	26	16
Mounjaro	Tirzepatide	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Propranolol Hcl	Propranolol Hcl	26	suppressed
Tradjenta	Linagliptin	26	suppressed
Glipizide Er	Glipizide	25	suppressed
Myrbetriq	Mirabegron	25	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Primidone	Primidone	24	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	24	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	23	suppressed
Lansoprazole	Lansoprazole	23	suppressed
Topiramate	Topiramate	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Fenofibrate	Fenofibrate,micronized	22	suppressed
Torsemide	Torsemide	22	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	21	suppressed
Amiodarone Hcl	Amiodarone Hcl	20	suppressed
Diazepam	Diazepam	20	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	19	suppressed
Brilinta	Ticagrelor	18	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Klor-Con M20	Potassium Chloride	17	suppressed
Mupirocin	Mupirocin	17	14
Valacyclovir	Valacyclovir Hcl	17	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	15
Hydrocortisone	Hydrocortisone	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Nitroglycerin	Nitroglycerin	16	14
Valsartan	Valsartan	16	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	15	suppressed
Epinephrine	Epinephrine	15	13
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Risperidone	Risperidone	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Cephalexin	Cephalexin	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	14	suppressed
Metronidazole	Metronidazole	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	13	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Dilantin	Phenytoin Sodium Extended	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Metformin Er Osmotic	Metformin Hcl	12	suppressed
Methenamine Hippurate	Methenamine Hippurate	12	suppressed
Naproxen	Naproxen	12	suppressed
Pentoxifylline	Pentoxifylline	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Invokana	Canagliflozin	11	suppressed
Omnipod Dash Pods (Gen 4)	Insulin Pump Cart,cont Inf,bt	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error